The Valley Desk

NCT01629667 · Interventional trial

A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis

Overall registry status Terminated

Phase 2

Conditions Idiopathic Pulmonary Fibrosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov